Paul Ruff to Carboplatin
This is a "connection" page, showing publications Paul Ruff has written about Carboplatin.
Connection Strength
0,045
-
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer. Gynecol Oncol. 2020 10; 159(1):142-149.
Score: 0,045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.